Publications

Mbwasi R, Mbepera D, Mfuko W, Makanzo J, Kikwale M, Canavan R, Stoermer M, Wiedenmayer K. Assessing public-private procurement practices for medical commodities in Dar es Salaam: a situation analysis. BMC Health Serv Res. 2022;22:1523. DOI: 10.1186/s12913-022-08923-1

Kuwawenaruwa A, Tediosi F, Metta E, Obrist B, Wiedenmayer K, Msamba V.S, Wyss K. Acceptability of a prime vendor system in public healthcare facilities in Tanzania. Int J Health Policy Manag. 2021;10(10):625-637. DOI: 10.34172/ijhpm.2020.90

Wiedenmayer K, Ombaka E, Kabudi B, Canavan R, Rajkumar S, Chilunda F, Sungi S, Stoermer M. Adherence to standard treatment guidelines among prescribers in primary healthcare facilities in the Dodoma region of Tanzania. BMC Health Serv Res. 2021;21:272. DOI: 10.1186/s12913-021-06257-y

Kuwawenaruwa A, Tediosi F, Obrist B, Metta E, Chiluda F, Wiedenmayer K, Wyss K. The role of accountability in the performance of Jazia prime vendor system in Tanzania. J Pharm Policy Pract. 2020;13:25. DOI: 10.1186/s40545-020-00220-8

Kuwawenaruwa A, Wyss K, Wiedenmayer K, Metta E, Tediosi F. The effects of medicines availability and stock-outs on household's utilization of healthcare services in Dodoma region, Tanzania. Health Policy Plan. 2020;35(3):323-333. DOI: 10.1093/heapol/czz173

Kuwawenaruwa A, Wyss K, Wiedenmayer K, Tediosi F. Cost and cost drivers associated with setting-up a prime vendor system to complement the national medicines supply chain in Tanzania. BMJ Glob Health. 2020;5(9):e002681. DOI: 10.1136/bmjgh-2020-002681

Wiedenmayer K, Msamba V.-S, Chilunda F, Kiologwe J.C, Seni J. Impact of hand hygiene intervention: a comparative study in health care facilities in Dodoma region, Tanzania using WHO methodology. Antimicrob Resist Infect Control. 2020;9(1):80. DOI: 10.1186/s13756-020-00743-4

Wiedenmayer K, Mbwasi R, Mfuko W, Mpuya E, Charles J, Chilunda F, Mbepera D, Kapologwe N. Jazia prime vendor system - a public-private partnership to improve medicine availability in Tanzania: from pilot to scale. J Pharm Policy Pract. 2019;12:4. DOI: 10.1186/s40545-019-0163-4

Jähnke R.W.O, Häfele-Abah C, Bonsmann C, Lange P, Silly I, Rabien D, Wiedenmayer K.A, Hauk C, Muzafarova N, Waning B, Heide l. Beispiele der pharmazeutischen Entwicklungszusammenarbeit. Pharmakon. 2018;6(5):398

Wiedenmayer K, Mbwasi R.O.J, Mfuko W.C. Complementing public-sector medicine supply through a public-private partnership in Tanzania: Jazia - a prime vendor system for Dodoma Region public health facilities. Medford: Management Sciences for Health (MSH), 2018

Wiedenmayer K. Swiss TPH - Pharmazie und Gesundheitssysteme. Pharmakon. 2018;6(5):398

Kapologwe N.A, Kagaruki G.B, Kalolo A, Ally M, Shao A, Meshack M, Stoermer M, Briët A, Wiedenmayer K, Hoffmann A. Barriers and facilitators to enrollment and re-enrollment into the community health funds/Tiba Kwa Kadi (CHF/TIKA) in Tanzania: a cross-sectional inquiry on the effects of socio-demographic factors and social marketing strategies. BMC Health Serv Res. 2017;17:308. DOI: 10.1186/s12913-017-2250-z

Nogier C, Hanlon P, Wiedenmayer K, Maire N. Can a compact pre-filled auto-disable injection system (cPAD) save costs for DTP-HepB-Hib vaccine as compared with single-dose (SDV) and multi-dose vials (MDV)? Evidence from Cambodia, Ghana, and Peru. Drugs Real World Outcomes. 2015;2(1):43-52. DOI: 10.1007/s40801-015-0010-0

Wiedenmayer K.A, Kapologwe N, Charles J, Chilunda F, Mapunjo S. The reality of task shifting in medicines management - a case study from Tanzania. J Pharm Policy Pract. 2015;8:13. DOI: 10.1186/s40545-015-0032-8

Wiedenmayer K.A, Rajkumar S, Ombaka E. Why making medicines available is not enough- a study in Tanzania exploring prescription and adherence to standard treatment guidelines. Trop Med Int Health, 2015;20(Suppl. 1):159

Kapologwe N, Mori A.T, Chilunda F, Meshack M, Kalolo A, Wiedenmayer K. Reforming supportive supervision of medicines management with an audit tool in primary health care facilities: a case study of Bahi districht, Tanzania. Int J Pharm. 2014;4(4):108-114

Nogier C, Hanlon P, Wiedenmayer K, Maire N. Is a compact prefilled auto-disable injection system (cPAD) cost effective for pentavalent vaccine?. Int J Infect Dis, 2014;21(Suppl. 1):438

Gentile A, Bhutta Z, Bravo L, Samy A.G, Garcia R.D, Hoosen A, Islam T, Karimi A, Salem M, Simasathien S, Sohail A, Watanaveeradej V, Wiedenmayer K, Schmitt H.J. Pediatric disease burden and vaccination recommendations: understanding local differences. Int J Infect Dis. 2010;14(8):e649-e658. DOI: 10.1016/j.ijid.2009.11.006

Wiedenmayer K, Bosch-Capblanch X, Hanlin R, Towse A, Tetteh E, Garau M. Baseline study for pneumococcal vaccine AMC. Basel: Swiss Centre for International Health, 2010

Wiedenmayer K. A new financing model for vaccine introduction. Bull Medicus Mundi. 2010(117):12-16

Erlanger T.E, Weiss S, Keiser J, Utzinger J, Wiedenmayer K. Past, present, and future of Japanese encephalitis. Emerg Infect Dis. 2009;15(1):1-7

Justin-Temu M, Nondo R.S, Wiedenmayer K, Ramaiya K.L, Teuscher A. Anti-diabetic drugs in the private and public sector in Dar es Salaam, Tanzania. East Afr Med J. 2009;86(3):110-114

Wiedenmayer K.A, Weiss S, Chattopadhyay C, Mukherjee A, Kundu R, Ayé R, Tediosi F, Hetzel M.W, Tanner M. Simplifying paediatric immunization with a fully liquid DTP-HepB-Hib combination vaccine: evidence from a comparative time-motion study in India. Vaccine. 2009;27(5):655-659. DOI: 10.1016/j.vaccine.2008.11.045

Gehler Mariacher G, Mtasiwa D, Wiedenmayer K, Bruppacher R, Tanner M, Hersberger K.E. Optimizing in-kind drug donations for Tanzania-a case study. Int J Health Plann Manage. 2008;23(4):313-344. DOI: 10.1002/hpm.901

Deutsche Gesellschaft für Technische Zusammenarbeit. Accelerating action: a technical support guide to develop capacity and to benefit from global health financing. Eschborn: Deutsche Gesellschaft für Technische Zusammenarbeit (GTZ), 2007

Gehler Mariacher G, Mtasiwa D, Wiedenmayer K, Bruppacher R, Tanner M, Hersberger K.E. In-kind drug donations for Tanzania: stakeholders' views - a questionnaire survey. World Health Popul. 2007;9(1):74-99

Wiedenmayer K. The pharmacist - a neglected workforce?. Bull Medicus Mundi. 2007(104):67-71

Tediosi F, Wiedenmayer K, Weiss S. Economic study on a fully liquid pentavalent vaccine. Basel: Novartis Vaccines, 2006

Wiedenmayer K, Summers R.S, Mackie C.A, Gous A.G.S, Everard M. Developing pharmacy practice: a focus on patient care : handbook 2006 edition. Geneva: World Health Organization, 2006. WHO/PSM/PAR/2006.5

Wiedenmayer K, Weiss S, Tediosi F. Time-motion study of a fully liquid pentavalent vaccine in Calcutta, India. Basel: Novartis Vaccines, 2006

Anderson S, Huss R, Summers R, Wiedenmayer K. Managing pharmaceuticals in international Health. Switzerland: Birkhäuser, 2004

Teuscher A, Wiedenmayer K. Natural insulin is cost-effective. Bull Medicus Mundi. 2002(84):29-31

Wiedenmayer K, Mtasiwa D. Transforming drug supply in Dar es Salaam. Essential Drugs Monitor. 2000(28-29):25-26

Teuscher A, Wiedenmayer K. Dezentralisierte Behandlung der Diabetes in Dar es Salaam. Bull Medicus Mundi. 1998(71):26-28

Wiedenmayer K, Lorenz N. Die Medikamentenpolitik des Schweizerischen Tropeninstituts: Richtlinien gemeinsam erarbeiten - und umsetzen!. Bull Medicus Mundi. 1998(68):8

Wiedenmayer K. Capacity building in der Ausbildung und Lehre. Bull Medicus Mundi. 1998(70):21-22

Wiedenmayer K. Printed material alone has little effect: improving rational drug use in Dar es Salaam, Tanzania, by elaborating and implementing Standard Treatment Guidelines (STG). Bull Medicus Mundi. 1998(68):23-26

Wiedenmayer K. Richtlinien gemeinsam erarbeiten- und umsetzen. Bull Medicus Mundi. 1998(68):8-9

Wiedenmayer K. Why worry about drug management. Bull Medicus Mundi. 1998(68):26-27

Wiedenmayer K. New Swiss drug legislation: control of drug export is necessary. Bull Medicus Mundi. 1996(61):18-19

Wiedenmayer K.A. 50 Jahre Schweizerisches Tropeninstitut 1943-1993. Schweiz Apothekerztg. 1994;132:8-11